Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19.
Saved in:
| Title: | Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19. |
|---|---|
| Authors: | Papi A; Respiratory Department, University of Ferrara, 44100, Ferrara, Italy. Alberto.papi@unife.it., Stapleton RD; Pulmonary and Critical Care Medicine, University of Vermont, Burlington, VT, USA., Shore PM; Clinical Development, CSL Behring, King of Prussia, USA., Bica MA; Global Clinical Safety and Pharmacovigilance, CSL Behring Innovation, Marburg, Germany., Chen Y; Biostatistics, CSL Behring, King of Prussia, USA., Larbig M; Clinical Development, CSL Behring AG, Bern, Switzerland., Welte T; Department of Pulmonary and Infectious Diseases, Hannover Medical School, Hannover, Germany. |
| Source: | Lung [Lung] 2023 Apr; Vol. 201 (2), pp. 159-170. Date of Electronic Publication: 2023 Mar 31. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Verlag Country of Publication: United States NLM ID: 7701875 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1750 (Electronic) Linking ISSN: 03412040 NLM ISO Abbreviation: Lung Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-1750 |
|---|---|
| DOI: | 10.1007/s00408-023-00615-9 |
